Transdermal Use of Lisuride in Early Parkinson's Disease: A double blind, randomized, Placebo and Pramipexole controlled study to evaluate the efficacy and safety of Lisuride TTS.

Trial Profile

Transdermal Use of Lisuride in Early Parkinson's Disease: A double blind, randomized, Placebo and Pramipexole controlled study to evaluate the efficacy and safety of Lisuride TTS.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 30 Jan 2014

At a glance

  • Drugs Lisuride (Primary) ; Pramipexole
  • Indications Parkinson's disease
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms TULEP-1
  • Sponsors axxonis Pharma
  • Most Recent Events

    • 22 Jul 2011 This trial is recruiting in Germany and Poland and has completed in Italy.
    • 22 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top